Johannes B. van Rees

1.8k citations

27 papers · 1.3k indexed · h-index 20

Co-authors: C. Jan Willem Borleffs Martin J. Schalij Lieselot van Erven Míhàly K. de Bie Joep Thijssen Jeroen J. Bax Theo Stijnen Suzanne C. Cannegieter
Topics: Cardiac pacing and defibrillation studies (24 papers)Cardiac Arrhythmias and Treatments (23 papers)Cardiac electrophysiology and arrhythmias (11 papers)
Cited by: Cardiology and Cardiovascular Medicine Neurology Medical Laboratory Technology
Journals: Journal of the American College of Cardiology European Heart Journal American Heart Journal
Partner nations: Netherlands United States

In The Last Decade

Johannes B. van Rees

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Johannes B. van Rees

Since Specialization

Citations

This map shows the geographic impact of Johannes B. van Rees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes B. van Rees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes B. van Rees more than expected).

Fields of papers citing papers by Johannes B. van Rees

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes B. van Rees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes B. van Rees. The network helps show where Johannes B. van Rees may publish in the future.

Co-authorship network of co-authors of Johannes B. van Rees

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes B. van Rees. A scholar is included among the top collaborators of Johannes B. van Rees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes B. van Rees. Johannes B. van Rees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study 2023 ·American Heart Journal ·(unknown),Pieter J. Vlaar,(unknown),(unknown),J.P. van Kuijk,Maarten A. Vink,Rohit M. Oemrawsingh,Sjoerd H. Hofma,Michael Magro,Wouter Remkes,Bart J.G.L. de Smet,Johannes B. van Rees,Samer Somi,(unknown),Frederik M. Zimmermann,Inge Wijnbergen,Jan G.P. Tijssen,Pim A.L. Tonino,Koen Teeuwen	4
2	Difficult Vascular Access in Urgent Coronary Artery Angiogram 2018 ·JACC: Cardiovascular Interventions ·Johannes B. van Rees,José M. Montero-Cabezas,Eidrees Ghariq,Martin J. Schalij	1
3	Super-Responders to Cardiac Resynchronization Therapy Remain at Risk for Ventricular Arrhythmias and Benefit from Defibrillator Treatment 2014 ·European Journal of Heart Failure ·(unknown),Ulas Höke,Joep Thijssen,C. Jan Willem Borleffs,Johannes B. van Rees,Enno T. van der Velde,Martin J. Schalij,Lieselot van Erven	28
4	Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice 2013 ·Heart ·Míhàly K. de Bie,Joep Thijssen,Johannes B. van Rees,Hein Putter,Enno T. van der Velde,Martin J. Schalij,Lieselot van Erven	38
5	Cost‐Effectiveness of Primary Prevention Implantable Cardioverter Defibrillator Treatment: Data from a Large Clinical Registry 2013 ·Pacing and Clinical Electrophysiology ·Joep Thijssen,M. Elske van den Akker‐van Marle,C. Jan Willem Borleffs,Johannes B. van Rees,Míhàly K. de Bie,Enno T. van der Velde,(unknown),MARTIN J. SCHALIJ	14
6	The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: Results from routine clinical practice 2012 ·Heart Rhythm ·Joep Thijssen,Johannes B. van Rees,Jeroen Venlet,C. Jan Willem Borleffs,Ulas Höke,Hein Putter,Enno T. van der Velde,Lieselot van Erven,Martin J. Schalij	26
7	Update on Small‐Diameter Implantable Cardioverter‐Defibrillator Leads Performance 2012 ·Pacing and Clinical Electrophysiology ·Johannes B. van Rees,Guido H. van Welsenes,C. Jan Willem Borleffs,Joep Thijssen,Enno T. van der Velde,Ernst E. van der Wall,Lieselot van Erven,Martin J. Schalij	17
8	Inappropriate Implantable Cardioverter-Defibrillator Shocks 2011 ·Journal of the American College of Cardiology ·Johannes B. van Rees,C. Jan Willem Borleffs,Míhàly K. de Bie,Theo Stijnen,Lieselot van Erven,Jeroen J. Bax,Martin J. Schalij	313
9	Implantable Cardioverter-Defibrillator Patients Who Are Upgraded and Respond to Cardiac Resynchronization Therapy Have Less Ventricular Arrhythmias Compared With Nonresponders 2011 ·Journal of the American College of Cardiology ·Joep Thijssen,C. Jan Willem Borleffs,Victoria Delgado,Johannes B. van Rees,Eline A.Q. Mooyaart,Rutger J. van Bommel,Lieselot van Erven,Eric Boersma,Jeroen J. Bax,Martin J. Schalij	44
10	Implantable cardioverter-defibrillator longevity under clinical circumstances: An analysis according to device type, generation, and manufacturer 2011 ·Heart Rhythm ·Joep Thijssen,C. Jan Willem Borleffs,Johannes B. van Rees,Sumche Man,Míhàly K. de Bie,Jeroen Venlet,Enno T. van der Velde,Lieselot van Erven,Martin J. Schalij	48
11	Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back-Up After an Event-Free First Battery Service-Life 2011 ·Journal of Cardiovascular Electrophysiology ·Guido H. van Welsenes,Johannes B. van Rees,Joep Thijssen,Serge A. Trines,Lieselot van Erven,Martin J. Schalij,C. Jan Willem Borleffs	27
12	Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices 2011 ·Journal of the American College of Cardiology ·Johannes B. van Rees,Míhàly K. de Bie,Joep Thijssen,C. Jan Willem Borleffs,Martin J. Schalij,Lieselot van Erven	203
13	Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures 2011 ·EP Europace ·Míhàly K. de Bie,(unknown),C. Jan Willem Borleffs,Johannes B. van Rees,Joep Thijssen,Serge A. Trines,Marianne Bootsma,Martin J. Schalij,Lieselot van Erven	23
14	Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach 2011 ·European Heart Journal ·Joep Thijssen,C. Jan Willem Borleffs,Johannes B. van Rees,Míhàly K. de Bie,Enno T. van der Velde,(unknown),J. J. Bax,Suzanne C. Cannegieter,M.J. Schalij	30
15	Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain 2011 ·EP Europace ·Johannes B. van Rees,C. Jan Willem Borleffs,Joep Thijssen,Míhàly K. de Bie,Lieselot van Erven,Suzanne C. Cannegieter,J. J. Bax,Martin J. Schalij	21
16	How to reduce the incidence of contrast induced acute kidney injury after cardiac (invasive) procedures, a review and practical recommendations 2011 ·Current Medical Research and Opinion ·Míhàly K. de Bie,Johannes B. van Rees,Charles A. Herzog,Ton J. Rabelink,Martin J. Schalij,J. Wouter Jukema	7
17	Cardiac device infections are associated with a significant mortality risk 2011 ·Heart Rhythm ·Míhàly K. de Bie,Johannes B. van Rees,Joep Thijssen,C. Jan Willem Borleffs,Serge A. Trines,Suzanne C. Cannegieter,Martin J. Schalij,Lieselot van Erven	60
18	Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients 2010 ·Journal of the American College of Cardiology ·C. Jan Willem Borleffs,Johannes B. van Rees,Guido H. van Welsenes,Enno T. van der Velde,Lieselot van Erven,Jeroen J. Bax,Martin J. Schalij	48
19	Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy 2010 ·Netherlands Heart Journal ·Guido H. van Welsenes,C. Jan Willem Borleffs,Johannes B. van Rees,Jael Z. Atary,Joep Thijssen,Ernst E. van der Wall,Martin J. Schalij	33
20	Implementation of Lead Safety Recommendations 2009 ·Pacing and Clinical Electrophysiology ·Johannes B. van Rees,C. Jan Willem Borleffs,Jeroen J. Bax,(unknown),Enno T. van der Velde,Lieselot van Erven,Martin J. Schalij	15

About Johannes B. van Rees

Johannes B. van Rees is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Emergency Medicine, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cardiac pacing and defibrillation studies (24 papers), Cardiac Arrhythmias and Treatments (23 papers) and Cardiac electrophysiology and arrhythmias (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Neurology (67 citations) and Medical Laboratory Technology (6 citations). Johannes B. van Rees has collaborated with scholars based in Netherlands and United States. Frequent co-authors include C. Jan Willem Borleffs, Martin J. Schalij, Lieselot van Erven, Míhàly K. de Bie, Joep Thijssen, Jeroen J. Bax, Theo Stijnen, Suzanne C. Cannegieter, Enno T. van der Velde and Guido H. van Welsenes. Their work appears in journals such as Journal of the American College of Cardiology, European Heart Journal and American Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact